Evaluation of Impaired Sedation in Patients With Moderate to Severe COVID-19 ARDS
Evaluation of Impaired Sedation in Patients With Moderate to Severe COVID-19 ARDS
This study focuses on the evaluation of various factors repeatedly discussed in relation to the impaired sedation of intubated ventilated COVID-19 patients. The sedation response of >100 moderately to severely affected COVID-19 ARDS was evaluated. The sedation level was measured at the bedside using the Richmond Agitation and Sedation Scale and ventilator synchrony. The evaluation was performed according to the static evaluation plan with respect to age, storage therapy and organ failure.
Inclusion Criteria:
moderate to severe COVID-19 ARDS
Exclusion Criteria:
None